Skip to main content

Oaktree Acquisition Corp. III Life Sciences

OACCW
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002029769

No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.65M in total; no superinvestor holds it.

Other share classesOACCOACCU

Q4 2024 vs. Q3 2024

How the institutions holding Oaktree Acquisition Corp. III Life Sciences changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of OACCW: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders012+12
Shares01.15M+1.15M
Value$0$941.9K+$941.9K

New holders (12)

Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to OACCW in Q4 2024
InstitutionSharesValue% of portfolio
CNH Partners LLC396,056$285.2K0.01%
Decagon Asset Management LLP181,986$159.9K0.07%
Shaolin Capital Management LLC134,000$117.8K0.00%
Walleye Capital LLC115,616$101.6K0.00%
Gritstone Asset Management LLC79,999$70.3K0.07%
ExodusPoint Capital Management, LP60,000$53.0K0.00%
Tenor Capital Management Co., L.P.60,000$52.7K0.00%
Sculptor Capital LP50,000$36.3K0.00%
K2 Principal Fund, L.P.39,058$34.4K0.01%
Verition Fund Management LLC34,050$29.9K0.00%
Clear Street LLC929$8160.00%
Highbridge Capital Management LLC–$880.00%

Sold out (0)

Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q3 2024 and filed for Q4 2024 without it.

None.